Avalyn Pharma Inc. · NASDAQ:AVLN

Norwest Venture Partners XV, LP reported a 5.10% stake in Avalyn Pharma Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 11, 2026

Norwest Venture Partners XV, LP reported a 5.10% stake in Avalyn Pharma Inc., 2,268,404 shares, as a passive investor on Jun 30, 2026. Filed Aug 11, 2026 (Schedule 13G).

Stake
5.10%
Shares
2,268,404
Intent
Passive
What changed
Crossed above 5%
Filed together
5 holders

The filing in full

HolderStakeShares
Norwest Venture Partners XV, LP5.10%2,268,404
Genesis VC Partners XV, LLC5.10%2,268,404
NVP Associates, LLC5.10%2,268,404
Jeffrey Crowe5.10%2,268,404
Jon Erik Kossow5.10%2,268,404

Source

View original at SEC

Related